共 215 条
- [1] Siegel RL(2021)Cancer statistics. CA Cancer J Clin 71 7-33
- [2] Miller KD(2021)Neoadjuvant chemotherapy in pancreatic cancer: an appraisal of the current high-level evidence Pharmacology 106 143-153
- [3] Fuchs HE(2011)FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer N Engl J Med 364 1817-1825
- [4] Jemal A(2013)Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine N Engl J Med 369 1691-1703
- [5] Müller PC(2021)Immunotherapy for pancreatic ductal adenocarcinoma J Surg Oncol 123 751-759
- [6] Frey MC(2020)Immunotherapy for pancreatic cancer: a 2020 update Cancer Treat Rev 86 102016-368
- [7] Ruzza CM(2021)Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment Biomaterials 268 120546-84
- [8] Nickel F(2021)Dilemma and challenge of immunotherapy for pancreatic cancer Dig Dis Sci 66 359-4201
- [9] Jost C(2020)The prognostic value of tumour-infiltrating lymphocytes in pancreatic cancer: a systematic review and meta-analysis Eur J Cancer 132 71-923
- [10] Gwerder C(2019)Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinoma PLoS One 14 e0219566-941